Hhlr Advisors LTD. Sells 99,596 Shares of Danaher Co. (NYSE:DHR)

Hhlr Advisors LTD. reduced its stake in shares of Danaher Co. (NYSE:DHRFree Report) by 91.6% in the third quarter, Holdings Channel reports. The firm owned 9,104 shares of the conglomerate’s stock after selling 99,596 shares during the period. Hhlr Advisors LTD.’s holdings in Danaher were worth $2,531,000 at the end of the most recent quarter.

A number of other hedge funds have also recently made changes to their positions in DHR. PGGM Investments purchased a new stake in shares of Danaher in the first quarter valued at approximately $459,000. Cetera Investment Advisers lifted its holdings in shares of Danaher by 338.0% in the 1st quarter. Cetera Investment Advisers now owns 122,223 shares of the conglomerate’s stock worth $30,522,000 after buying an additional 94,318 shares during the period. Cetera Advisors LLC grew its position in shares of Danaher by 44.3% during the 1st quarter. Cetera Advisors LLC now owns 27,346 shares of the conglomerate’s stock worth $6,829,000 after buying an additional 8,389 shares in the last quarter. Cetera Advisor Networks LLC increased its stake in shares of Danaher by 6.3% during the first quarter. Cetera Advisor Networks LLC now owns 72,454 shares of the conglomerate’s stock valued at $18,093,000 after buying an additional 4,266 shares during the period. Finally, EverSource Wealth Advisors LLC raised its holdings in shares of Danaher by 5.3% in the first quarter. EverSource Wealth Advisors LLC now owns 1,366 shares of the conglomerate’s stock valued at $337,000 after acquiring an additional 69 shares in the last quarter. 79.05% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research analysts have issued reports on the stock. Stifel Nicolaus increased their target price on shares of Danaher from $250.00 to $265.00 and gave the stock a “hold” rating in a report on Wednesday, October 23rd. UBS Group dropped their price objective on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. Robert W. Baird reduced their price objective on shares of Danaher from $278.00 to $277.00 and set an “outperform” rating for the company in a research note on Wednesday, October 23rd. Stephens reaffirmed an “overweight” rating and set a $315.00 target price on shares of Danaher in a research report on Wednesday, October 23rd. Finally, KeyCorp lifted their price target on Danaher from $290.00 to $310.00 and gave the company an “overweight” rating in a report on Wednesday, October 23rd. Five research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to data from MarketBeat, Danaher currently has a consensus rating of “Moderate Buy” and a consensus price target of $287.16.

Read Our Latest Stock Analysis on DHR

Danaher Stock Up 0.4 %

Shares of DHR opened at $239.84 on Friday. The stock’s 50-day moving average price is $254.59 and its 200-day moving average price is $259.44. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $173.23 billion, a price-to-earnings ratio of 45.77, a PEG ratio of 4.39 and a beta of 0.85. Danaher Co. has a 52 week low of $215.68 and a 52 week high of $281.70.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings data on Tuesday, October 22nd. The conglomerate reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.57 by $0.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. The business had revenue of $5.80 billion for the quarter, compared to analysts’ expectations of $5.59 billion. During the same quarter last year, the company earned $2.02 EPS. The business’s revenue was up 3.1% on a year-over-year basis. On average, sell-side analysts predict that Danaher Co. will post 7.5 EPS for the current year.

Danaher Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, October 25th. Investors of record on Friday, September 27th were paid a $0.27 dividend. The ex-dividend date of this dividend was Friday, September 27th. This represents a $1.08 annualized dividend and a dividend yield of 0.45%. Danaher’s dividend payout ratio is presently 20.61%.

About Danaher

(Free Report)

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.

See Also

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHRFree Report).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.